Amyloid-beta at sublethal level impairs BDNF-induced arc expression in cortical neurons

Area of Science:

• Neuroscience
• Molecular Biology
• Neurodegenerative Diseases

Background:

• Alzheimer's disease (AD) involves memory loss and cognitive decline, linked to impaired synaptic plasticity.
• Brain-derived neurotrophic factor (BDNF) is crucial for synaptic plasticity, and activity-regulated cytoskeleton-associated protein (Arc) is a downstream effector.
• Amyloid-beta (Abeta) peptides, characteristic of AD pathology, may disrupt synaptic signaling even at sublethal concentrations.

Purpose of the Study:

• To investigate whether sublethal amyloid-beta (Abeta) affects BDNF-induced Arc protein expression in early Alzheimer's disease.
• To elucidate the impact of Abeta on the BDNF signaling pathway crucial for synaptic plasticity.

Main Methods:

• Primary cultures of neonatal rat cortical neurons were utilized.
• Neurons were treated with BDNF to induce Arc protein expression.
• The effect of sublethal Abeta (5 microM) on BDNF-induced Arc expression was assessed.

Main Results:

• BDNF successfully induced Arc protein expression in a dose- and time-dependent manner.
• Sublethal Abeta treatment significantly suppressed the level of BDNF-induced Arc protein expression.
• This indicates Abeta interferes with BDNF-mediated signaling pathways.

Conclusions:

• Sublethal amyloid-beta impairs BDNF-mediated Arc protein synthesis in cortical neurons.
• This impairment of synaptic plasticity signaling may underlie cognitive deficits in early Alzheimer's disease.
• The findings highlight a potential mechanism for early AD pathogenesis prior to significant neuronal loss.